Lung Cancer Screening Program

Lung Cancer Screening Program

The primary goal of low-dose computed tomography (LDCT) lung cancer screening is to detect lung cancer at curable stages while minimizing harm to those without lung cancer. Since 2015, Cleveland Clinic’s lung cancer screening program has performed > 15,000 LDCTs, with > 4,000 in 2020. More than 160 lung cancers have been diagnosed through screening in the past three years.

In 2020, the COVID-19 pandemic impacted our screening program. From mid-March through mid-June we closed the program to all new and annual visits. When the program re-opened we converted the majority of our shared decision-making visits to telehealth visits. Compliance with annual visits was delayed. We have recovered to our pre-pandemic baseline and have learned lessons that will help us to grow while insuring the highest quality screening over time.

The Percentage of Individuals Who Complete LDCT Screening for Lung Cancer Who are Screen-Eligible Based on the USPSTF Criteria (N = 4335)

2020

Percentage of Current Smokers who Participated in LDCT Screening That Have Documentation of a Smoking Cessation Intervention¹ (N = 1789)

2020

¹Based on percentage of people who currently smoke who participate in LDCT screening who have documentation of a smoking cessation intervention (e.g. discussion, an offer to participate in a smoking cessation program) during the shared decision-making visit.

Percentage of Lung Cancer LDCT Screen Eligible Individuals who Complete a LDCT Exam and are Identified to Have LungRADS Category 1 or 2 Findings who Complete the Next Annual LDCT Screening Exam (N = 3329)

2020

Percentage of Individuals who Complete a LDCT Lung Cancer Screening Exam and Were Identified to Have a LungRADS Category 3 Nodule in Which a Surveillance LDCT Scan is Performed at 6 Months (+/- 2 months) (N = 337)

2020

Percentage of Individuals who Complete a LDCT Lung Cancer Screening Exam and Were Identified to Have a LungRADS Category 4 (A) Nodule in Which a Surveillance LDCT Scan (CT or PET) is Performed at 3 Months (+/- 6 weeks) (N = 175)

2020

LungRADSPrematureAdherentOverdue
1<10 months10-18 months> 18 months
2<10 months10-18 months> >18 months
3<4 months4-8 months> >8 months
4A<50 days50-134 days> >134 days
Time from Identification of a LungRADS Category 4B or 4X Lung Nodule/Mass on a LDCT Screening Exam to the Diagnosis of Lung Cancer (N = 63)

2020